Newswise - Diarrhea could be diagnosed more successfully thanks to a new diagnostic test devised by researchers at the University of Bristol and the University of the West of England, UK. It is anticipated that this will lead to the development of a device capable of rapid diagnosis at the bedside, saving both lives and money.
The new test produces a chemical fingerprint for different strains of viral and bacterial infection and allows them to be differentiated from `normal' controls, according to a recent report published in the British medical journal Gut.
The report is the result of a two-year collaboration between professor Norman Ratcliffe at the University of the West of England and Dr. Chris Probert from the School of Medicine at the University of Bristol, who is also a consultant physician at Bristol Royal Infirmary.
"There are numerous kinds of infection that cause diarrhea and it is important to ensure that the correct diagnoses is made so that the correct treatment can be prescribed," Probert said. "Diagnosis currently requires a microbiological stool analysis which can take up to eight days for results to be obtained. This delay is caused by the need to transport samples to an appropriate laboratory, and the time required to complete the diagnostic techniques. In extreme cases samples have been flown from Asia to the United States for tests, allowing the disease to spread and kill in the meantime. Hospitals wards in the UK have sometimes had to close because of the fast spread of viruses that are not detected early enough for infected patients to be isolated. This causes enormous strain on hospital resources and of course it can be very expensive."
Ratcliffe, who leads the team of researchers at UWE, explains, "This test has the potential to reduce mortality and unnecessary suffering and, crucially, the spread of infection. It has long been known that stools have distinctive and different odors if there is an infection. What we have done is to take this `knowledge' a step further by analyzing the odor to see if precise chemical fingerprints can be established. Put simply, the odors, or `volatiles' from normal, bacterial and viral stools differ significantly in their chemical composition. By using portable instruments we can identify which volatiles are found in a stool sample in less than an hour of the sample collection being made, and use this information to make a rapid diagnosis. This study is about to enter its second phase where a larger population of infected samples will be analyzed. The ultimate goal will be to develop a portable vapor analysis machine, capable of diagnosing at the bedside."
This pilot project has the potential to save lives and reduce the cost burden to the NHS. Early isolation of infectious patients would reduce hospital outbreaks leading to fewer ward/hospital closures. Early diagnosis would lead to more appropriate use of antibiotics. Diarrhea is a major cause of morbidity and mortality in developing countries and costs the NHS £60 million each year. Every year in England and Wales there are 15,000 cases of Clostridium difficile infection, one of the most common causes of diarrhea, and worldwide, 6,800 children die every day from diarrheal disease.
Source: University of Bristol
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
The Long-Term Care Chronicles: The Great Mitigators
August 27th 2024Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.
Navigating Infection Prevention Challenges Amid 2024 Outbreaks: Strategies for Success
August 22nd 2024As infectious diseases resurge in 2024, this article explores how IPs can manage outbreaks, allocate resources, use technology for surveillance, and collaborate with senior leaders to ensure business continuity and patient safety in health care settings.